156 related articles for article (PubMed ID: 19370184)
1. Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vgamma9/Vdelta2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?
Giardina AR; Accardo-Palumbo A; Ciccia F; Ferrante A; Principato A; Impastato R; Triolo G
Reumatismo; 2009; 61(1):21-6. PubMed ID: 19370184
[TBL] [Abstract][Full Text] [Related]
2. Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity.
Accardo-Palumbo A; Giardina AR; Ciccia F; Ferrante A; Principato A; Impastato R; Giardina E; Triolo G
Arthritis Res Ther; 2010; 12(3):R109. PubMed ID: 20525258
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
Hamdi H; Mariette X; Godot V; Weldingh K; Hamid AM; Prejean MV; Baron G; Lemann M; Puechal X; Breban M; Berenbaum F; Delchier JC; Flipo RM; Dautzenberg B; Salmon D; Humbert M; Emilie D;
Arthritis Res Ther; 2006; 8(4):R114. PubMed ID: 16859506
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
5. Selective depression of interferon-gamma and granulysin production with increase of proliferative response by Vgamma9/Vdelta2 T cells in children with tuberculosis.
Dieli F; Sireci G; Caccamo N; Di Sano C; Titone L; Romano A; Di Carlo P; Barera A; Accardo-Palumbo A; Krensky AM; Salerno A
J Infect Dis; 2002 Dec; 186(12):1835-9. PubMed ID: 12447771
[TBL] [Abstract][Full Text] [Related]
6. The effect of etanercept and infliximab on the production of tumour necrosis factor alpha, interferon-gamma and GM-CSF in in vivo activated intestinal T lymphocyte cultures.
Agnholt J; Dahlerup JF; Kaltoft K
Cytokine; 2003 Aug; 23(3):76-85. PubMed ID: 12906870
[TBL] [Abstract][Full Text] [Related]
7. Cytokine production from stimulated whole blood cultures in rheumatoid arthritis patients treated with various TNF blocking agents.
Popa C; Barrera P; Joosten LA; van Riel PL; Kullberg BJ; van der Meer JW; Netea MG
Eur Cytokine Netw; 2009 Jun; 20(2):88-93. PubMed ID: 19541595
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients.
Nobre CA; Callado MR; Lima JR; Gomes KW; Martiniano GV; Vieira WP
Rheumatol Int; 2012 Sep; 32(9):2769-75. PubMed ID: 21822912
[TBL] [Abstract][Full Text] [Related]
9. Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy.
Popa C; Netea MG; Barrera P; Radstake TR; van Riel PL; Kullberg BJ; Van der Meer JW
Cytokine; 2005 Apr; 30(2):72-7. PubMed ID: 15804598
[TBL] [Abstract][Full Text] [Related]
10. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.
Aeberli D; Seitz M; Jüni P; Villiger PM
Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629
[TBL] [Abstract][Full Text] [Related]
11. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
[TBL] [Abstract][Full Text] [Related]
12. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis.
Murakami S; Takeno M; Kirino Y; Kobayashi M; Watanabe R; Kudo M; Ihata A; Ueda A; Ohno S; Watanuki Y; Kaneko T; Ishigatsubo Y
Tuberculosis (Edinb); 2009 Mar; 89(2):136-41. PubMed ID: 19211305
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy.
Coury F; Ferraro-Peyret C; Le Cam S; Guerin S; Tebib J; Sibilia J; Bienvenu J; Fabien N
Clin Exp Rheumatol; 2008; 26(2):234-9. PubMed ID: 18565243
[TBL] [Abstract][Full Text] [Related]
14. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
[TBL] [Abstract][Full Text] [Related]
15. Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease.
Triolo G; Accardo-Palumbo A; Dieli F; Ciccia F; Ferrante A; Giardina E; Sano CD; Licata G
Arthritis Res Ther; 2003; 5(5):R262-8. PubMed ID: 12932289
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study.
Talotta R; Berzi A; Atzeni F; Dell'Acqua D; Sarzi Puttini P; Trabattoni D
Reumatismo; 2016 Sep; 68(2):83-9. PubMed ID: 27608796
[TBL] [Abstract][Full Text] [Related]
17. Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection.
Biswas P; Ferrarini M; Mantelli B; Fortis C; Poli G; Lazzarin A; Manfredi AA
Eur J Immunol; 2003 Jan; 33(1):252-63. PubMed ID: 12594854
[TBL] [Abstract][Full Text] [Related]
18. Vdelta2+ gammadelta T cell function in Mycobacterium tuberculosis- and HIV-1-positive patients in the United States and Uganda: application of a whole-blood assay.
Rojas RE; Chervenak KA; Thomas J; Morrow J; Nshuti L; Zalwango S; Mugerwa RD; Thiel BA; Whalen CC; Boom WH
J Infect Dis; 2005 Nov; 192(10):1806-14. PubMed ID: 16235181
[TBL] [Abstract][Full Text] [Related]
19. Low prevalence of reactive PPD prior to infliximab use: comparative study on a population sample of Hospital Geral de Fortaleza.
Callado MR; Lima JR; Nobre CA; Vieira WP
Rev Bras Reumatol; 2011; 51(1):40-52. PubMed ID: 21412605
[TBL] [Abstract][Full Text] [Related]
20. The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: a prospective study.
Klaasen R; Thurlings RM; Wijbrandts CA; van Kuijk AW; Baeten D; Gerlag DM; Tak PP
Arthritis Rheum; 2009 Nov; 60(11):3217-24. PubMed ID: 19877042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
